1[1]Black HR. New concepts in hypertension:Focus on the elderly. Am Heart J, 1998;135(2,part2):S2～S7
2[2]Weinberger MH, Fawzy Z. Doxazosin in elderly patients with hypertension. Int J Clin Pract, 2000;54(3):181～189
3[3]Holzgreve H. Therapeutic needs of the elderly patient. J Cardiovasc Pharmacol,1998;31(Suppl 2):S22～S26
4[4]Gueyffer F, Bulpitt C, Boissel JP et al. Antihypertensive drugs in very old people:a subgroup metaanalysis of randomised controlled trials. Lancet, 1999;353(9155):793～796
5[5]White WB. Benefits of antihypertensive therapy in older patients with hypertension. Arch Intern Med, 2000;160(2):149～150
6[6]Staessen JA, Gasowski J, Wang JG et al. Risks of untreated and treated isolated systolic hypertension in the elderly:Meta-analysis of outcome trias. Lancet, 2000;355(9207):865～872
7[7]Rosenberg L, Rao RS, Palmer JR et al. Calcium channel blockers and the risk of cancer. JAMA, 1998;279(13):1000～1004
8[8]Cases A. Advances in hypertension management:Update 1998. Drug Today, 1998;34(12):989～994
9[9]Cohen HJ, Pieper CF, Hanlon, JT et al. Calcium channel blocker and cancer. Am J Med, 2000;108(3):210～215
10[10]Pickering TG. Advances in the treatment of hypertension. JAMA,1999;281(2):114～116
